Live
AgilentMassachusetts Financial Services Co. MA Raises Stock Position in Agilent Technologies, Inc. $A - MarketBeatEndpoints NewsMore pharma dealmaking; FDA’s proposed budget; Takeda ends partnership; and moreThermo FisherIs It Too Late To Consider Thermo Fisher Scientific (TMO) After Recent Share Price Weakness? - Yahoo FinanceThermo FisherThermo Fisher expands global biobank leadership through collaboration with PRECISE-SG100K Singapore - BioSpectrum AsiaBioWorldSecond CRL for Replimune’s RP-1 for melanomaFierceBiotechFDA rejects Replimune’s melanoma prospect for second timeEndpoints NewsPlan for remade ACIP panel adds focus on vaccine safety, matching Kennedy’s pushEndpoints NewsBayer pharma executive predicts US-Europe price spreads will narrowBioWorldMoney raised by biopharmaBioWorldBiopharma money raised: Jan. 1-April 9, 2026Endpoints NewsFDA rejects Replimune cancer therapy, saying company didn't resolve trial doubtsBioPharma DiveFDA again spurns Replimune melanoma drug
Thermo Fisher Apr 11, 2026

Is It Too Late To Consider Thermo Fisher Scientific (TMO) After Recent Share Price Weakness? - Yahoo Finance

Is It Too Late To Consider Thermo Fisher Scientific (TMO) After Recent Share Price Weakness? - Yahoo Finance

Original
Body unavailable. Use the original source.

Directory

59 All